/
DCF Valuation
Base-case fair value
$1015.04
Intrinsic $1353.39 · 25% MOS
Current price: $134.41
Base-case summary
Our base-case DCF for Nutex Health Inc. (NUTX) projects 10 years of free cash flow growth at 14.5% for years 1–5 and 7.3% for years 6–10, anchored to 14.5% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $269M in trailing free cash flow, this produces an intrinsic value of $1353.39 per share. A 25% safety margin gives a fair value of $1015.04, suggesting the stock is currently 655% undervalued against the $134.41 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$269M
Cash & equivalents
$207M
Total debt
$349M
Shares outstanding
7M